Form D · Pharmaceuticals
Med Aditus Pharmaceuticals, Inc.
Rtp, NC · CIK 0002041640
Offering snapshot reported Nov 6, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 6, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-528755
Source: Form D, filed Nov 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mary Gunn | Director |
| Khama Rogo | Director |
| David Stefanich | Director |
| Dhiren R. Thakker | Director, Executive |
| Kay P. Wagoner | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
800 Park Offices Drive, Suite 3604
Rtp, NC, 27709
Rtp, NC, 27709